Showing results (151-160 of 238) with videos related to

Sort By:
Pageof 24
Clinical and Experimental Obstetrics & Gynecology|June 9, 2012
The trend of VEGF-A and PlGF in pregnant patients: a perspective case-control study on 214 womenT S Patrelli, S Gizzo, M Plebani, et al.
Enzyme|January 1, 1987
Molecular size distribution of immunoreactive trypsin and renal tubular dysfunction: role in trypsin plasma-urine transferC Fabris, L Benini, G Del Favero, et al.
Clinical Physiology and Biochemistry|January 1, 1990
Renal handling of amylase and immunoreactive trypsin in pancreatic cancer and chronic pancreatitisC Fabris, D Basso, G Del Favero, et al.
The American Journal of Gastroenterology|February 19, 1998
Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influences serologyF Navaglia, D Basso, M G Piva, et al.
Oncology|January 1, 1995
Is CA242 really a new tumour marker for pancreatic adenocarcinoma?M Plebani, D Basso, F Navaglia, et al.
Cell Transplantation|October 10, 2014
Exogenous adult postmortem neural precursors attenuate secondary degeneration and promote myelin sparing and functional recovery following experimental spinal cord injuryStephana Carelli, Toniella Giallongo, Giovanni Marfia, et al.
Disease Markers|July 1, 1988
Serum carcinoembryonic antigen in the differential diagnosis of pancreatic cancer: influence of tumour spread, liver impairment, and ageD Basso, C Fabris, G Del Favero, et al.
The American Journal of Gastroenterology|May 1, 1988
Serum markers and clinical data in diagnosing pancreatic cancer: a contrastive approachC Fabris, G Del Favero, D Basso, et al.
Minerva Medica|April 14, 1986
[The role of CEA, CA 19-9 and TPA in the diagnosis of pancreatic cancer. Evaluation by discriminant analysis]D Basso, C Fabris, G Del Favero, et al.
The Italian Journal of Gastroenterology|February 1, 1990
How does liver dysfunction influence serum CA 19-9 in pancreatic cancer?D Basso, C Fabris, G Del Favero, et al.
Pageof 24